×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [17]
山东大学 [14]
四川大学 [11]
合肥物质科学研究院 [7]
吉林大学白求恩第一医... [4]
湖南大学 [3]
更多...
内容类型
期刊论文 [58]
会议论文 [11]
学位论文 [1]
发表日期
2022 [2]
2021 [5]
2019 [2]
2018 [13]
2017 [10]
2016 [3]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共70条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Dorsal incision shows more efficacy and safety to traditional incision in single-portal video-assisted thoracoscopic surgery segmentectomy of LS9+10: a non-randomized prospective clinical trial
期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:
Luo, Taobo
;
Chen, Qixun
;
Zeng, Jian
;
Cai, Lei
;
Huang, Xiancong
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
Segmentectomy
LS9+10
dorsal incision
High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Fan, Y.
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2022/12/23
NSCLC
EGFR TKI
Brain Metastases
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
期刊论文
THORACIC CANCER, 2021
作者:
Shi, Yuequan
;
Fang, Jian
;
Zhou, Chengzhi
;
Liu, Anwen
;
Wang, Yan
收藏
  |  
浏览/下载:66/0
  |  
提交时间:2022/01/25
advanced lung cancer
immune checkpoint inhibitors
immune-related adverse events
real-world data
ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:
Cheng, Y.
;
Wang, J.
;
Cang, S.
;
Cao, L.
;
Chen, E.
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2021/04/26
Anlotinib plus Docetaxel versus Docetaxel as 2nd Line Treatment in Advanced Non-Small Cell Lung Cancer: A Phase I/II Study
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:
Fang, Y.
;
Pan, H.
;
Shou, J.
;
Hong, W.
;
Yang, X.
收藏
  |  
浏览/下载:56/0
  |  
提交时间:2021/05/17
Anlotinib
NSCLC
anti-angiogenesis
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
期刊论文
CLINICAL EPIGENETICS, 2021, 卷号: 13
作者:
Li, Hong
;
Ma, Liying
;
Bian, Xing
;
Lv, Yang
;
Lin, Wenchu
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2021/04/26
Small cell lung cancer
FK228
Histone deacetylase
PI3K
Radioresistance
DNA damage repair
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12
作者:
Shen, Dijian
;
Chen, Qixun
;
Wu, Jie
;
Li, Jianqiang
;
Tao, Kaiyi
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2021/04/26
Neoadjuvant immunotherapy
esophageal squamous cell carcinoma (ESCC)
thoracic surgery
programmed death 1 (PD-1)
Generation of an induced pluripotent stem cell line (SDQLCHi003-a) from a patient with short rib-thoracic dysplasia syndrome type III carrying compound heterozygous mutations in DYNC2H1
期刊论文
STEM CELL RESEARCH, 2019, 卷号: 39
作者:
Zhang, Haiyan
;
Ma, Yanyan
;
Song, Fengling
;
Yang, Xiaomeng
;
Li, Yue
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/11
A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S304-S304
作者:
Wu, Y.
;
Han, B.
;
Shi, M.
;
Tu, H.
;
Gu, A.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
advanced non-small cell lung cancer
Polymeric micelle paclitaxel
(pm-Pac) /cisplatin
randomized phase III clinical trial
Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer
会议论文
作者:
Cui, J.
;
Zhao, J.
;
Wang, Z.
;
Ma, Z.
;
Shu, Y.
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
lung cancer
tislelizumab (BGB-A317)
Chemotherapy combination
©版权所有 ©2017 CSpace - Powered by
CSpace